Aspirin Therapy for Vascular Disorders
Physicians across the country agree that daily use of aspirin for prevention of vascular disorders is controversial (Neale, 2014). Dr. J. Jaques Carter of Harvard Medical School and Beth Israel Deaconess Medical Center in Boston admits that he used to recommend a daily aspirin to all of his middle-aged adult patients, regardless of vascular disease risk factors being present, as it was standard procedure at the time (Neale, 2014). Dr. Len Horovitz of Lenox Hill Hospital in New York City explains that the FDA guidelines regarding “routine” prescription of aspirin for men and women over age 55 and 65 respectively have changed as studies have demonstrated the greater risk of GI bleeding
…show more content…
This paper will explore the benefits and risks of routine use of aspirin therapy in the treatment of vascular disease and prevention of its concurrent complications. According to Burchum & Rosenthal (2016) five major “risk factors for heart disease are age, gender, cholesterol levels, blood pressure, and smoking status”. If you fit this profile, a daily aspirin might be recommended as you are at high risk for having your first heart attack, may have had a heart attack or stroke in the past and as long as you do not have a history of bleeding or clotting disorders (Mayo Clinic, 2016). The benefit of a daily aspirin would be to prevent platelets from sticking together and forming a blockage where a vessel is damaged due to disease or lifestyle or may be narrowed from fat deposits or atherosclerosis (Mayo Clinic, 2016). VanWormer et al. (2012) proposed that aspirin therapy is actually under-utilized by high-risk patients and over-utilized by those at low risk for cardiovascular disease where the risk of bleeding is greater than the possible benefits. Having limited data regarding the sociodemographic variables of aspirin use, VanWormer et al. (2012) set about creating a study to evaluate these variables among adults in Wisconsin without a history of cardiovascular disease. Using guidelines for aspirin use established by the US Preventive Services
Warfarin is used most often for long-term prophylaxis of thrombosis. “Specific indications are (1) prevention of venous thrombosis and associated pulmonary embolism, (2) prevention of thromboembolism in patients with prosthetic heart valves, and (3) prevention of thrombosis during atrial fibrillation.”(Lehne, 2010, p. 605). Warfarin is the oral anticoagulant of choice for these indications. The drug has also been used to reduce the risk of recurrent transient ischemic attacks (TIA) and recurrent myocardial infarction (MI).(Lehne, 2010).
many different medicines are used to treat coronary heart disease. Usually they aim to reduce blood pressure or widen your arteries. For example antiplatelet are a type of medicine that can help reducing the risk of a heart attack by thinning your blood and preventing it from clotting. However there are also side effects after taking the medication like dizziness, diarrioah, nose bleeds and abdominal pain.
In this discussion board, I will review the findings and recommendations of the United States Preventive Service Task Force (USPSTF) recommendation statement: Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer.
The safest and often most effective courses of action are normally exercise, nutrition, and work-life balance, but doctors who do not prescribe lifestyle changes instead of drugs would probably soon find themselves out of business. Informed patients who have done research on websites such as WebMD and Rxlist.com believe that they know what drug will best treat their symptoms and seek out doctors who will prescribe what they want. Financial considerations should not be the driving force of medical decision-making. Though tempting, prescription drugs are often not the best course of action to improve health and treat symptoms. Doctors
Many organizations have developed practice guidelines for a myriad of clinical scenarios which include the use of specific drugs or classes of medications, typically in a step-wise pattern. These “Best Practice” guidelines are built on evidence based criteria and systematic reviews. It has been shown that these clinical guidelines, with their list of essential medications, improve the quality of care and lead to better outcomes, but have not been shown to reduce costs.4,5 The practice of medicine has moved dramatically towards the use of these guidelines in recent years. For example, best practices for diabetic care recommends that all patients be placed on an ACE (angiotensin converting enzyme) inhibitor or ARB (angiotensin receptor blocker) for prevention of diabetic nephropathy and a statin for prevention of coronary artery disease. However, each patient’s insurance may cover a different medication in this class
The evidence based practice process gives more evidence of young patients with few risk factors and no structural heart defect, the benefits of anticoagulation may be outweighed by the risks of haemorrhage (bleeding). High quality guidelines and the systematic searches used for the topic in this portfolio were beneficial. Use of a rigorous and transparent process in this portfolio for identifying, appraising and adopting/ adapting guidelines are crucial to help for the decision making. A major factor that stops the usage of the new drug is unfortunately, there are no specific antidotes to reverse the coagulant effects of the direct thrombin or factor Xa
Stroke was defined as the sudden onset of a focal neurologic deficit in a location associated with the area of a major cerebral artery. The primary safety outcome was major hemorrhage and was defined as a reduction in the hemoglobin level of at least 20 g/L, transfusion of at least 2 units of blood, or symptomatic bleeding in a critical organ or area. Results were calculated using the Cox proportional-hazards modeling. Systolic embolism or stroke occurred in 199 patients receiving warfarin, 182 patients receiving 110 mg of dabigatran twice daily, and in 134 patients receiving dabigatran 150 mg twice daily. Major bleeding events occurred in 3.36% of participants per year with warfarin, 2.71% per year in patients that received 110 mg of dabigatran, and 3.11% per year in those receiving 150 mg of dabigatran. From calculated data, results revealed that dabigatran administered at a dose of 110 mg twice daily was non-inferior to that of warfarin. Lower rates of stroke were associated with dabigatran administered at a dose of 150 mg twice daily compared with that of warfarin. For safety, it was concluded that the risk of bleeding was lowest with dabigatran 110mg twice daily, and was similar between dabigatran 150 mg twice daily and
There are many people that suffer from venous thromboembolism. Venous thromboembolism includes both deep vein thrombosis and pulmonary embolism. This is the third most common cause of vascular death after a myocardial infarction, also known as a heart attack, and stroke. This article examines the possibility of either full or low intensity anticoagulation therapy versus aspirin. This was a randomized study that consisted of 3,396 individuals who have venous thromboembolism. These individuals either received rivaroxaban, which is an anticoagulant, or 100 mg of aspirin once a day. The individuals in this study completed 6-12 months of anticoagulation therapy and were eligible for inclusion in the study if they were 18 years of age or older. The
Atrial fibrillation is the most frequent cardiac arrhythmia. There has always associated risk of clot formation and embolization that can lead to ischemic stroke. A large number of these ischemic events could be prevented by timely anticoagulation. Warfarin has been used for decades for this purpose, but there are many problems for the patients due to warfarin therapy like there is continuous need of INR monitoring, many food and drug interactions of the drug, late onset of action and risk of major bleeding. Anticoagulation with the Novel oral anticoagulants e.g. Dabigatran, rivaroxaban, apixaban, endoxaban led to similar or even lower rates of ischemic stroke and major bleeding compared to an adjusted dose of warfarin (INR 2-3) in patients
As late as about seven decades ago, elevated blood pressure was considered by many expert physicians to be necessary for the adequate perfusion of vital organs. It was deemed as an unavoidable, hence essential, component of the aging process leading to the coining of the term “essential hypertension”. High blood pressure (BP) was considered as probable natural and necessary compensatory phenomenon that should be left alone even if there were effective treatments (Hay, 1931; White, 1937). This notion was further strengthened by the observed elevated misery and premature death recorded for the patients that were treated for hypertension with the few drugs that were available at the time compared to those that were left untreated (Goldring,
Patient education: Maintaining optimal blood pressure reduces the incidence of stroke by 35-40% as well as reducing the incidence of myocardial infarction and heart failure. As well as pulmonary embolus, the patient is at a greater risk for heart disease stroke due to his risk factors of age greater than 60 years, history of smoking, hypertension, diabetes and high cholesterol. Blood clots in deep veins can lead to stroke over time. Therefore, the risk of heart disease
The period entered for the search was from January 2002 to August 2015. The Search terms were: “dual antiplatelet therapy”, “shortened DAPT”,”, “clopidogrel”, “early discontinuation”, “Drug-eluting stenting in diabetes mellitus AND Dual Antiplatelet Therapy”, “extended DAPT”, “prolonged DAPT”, “gastroenteritis AND clopidogrel”, “Delayed eosinophilic gastroenteritis and gastroenteritis”, “thienopyridine”, “P2Y12”, “premature cessation “drug eluting stents AND diabetes” , “duration of dual antiplatelet therapy”. The search had to be modified to include patient’s co-morbidities, medications and medical condition. The search initially started with optimal duration of dual antiplatelet therapy in patients after drug-eluting stent revascularization, and then the search was broadened to include diabetic patients with drug-eluting stent. Lastly I included gastroenteritis to unearth any relation between clopidogrel and Mrs GL’s hospital admittance.
Statins has multiple organ effects by affecting the liver, musculoskeletal system and the nervous system, controlled clinical trials with randomized blinded assignment of treatment groups to patients treated with statins and placebo was conducted, hence valid data about adverse effects of statins were obtained (doc1.pdf-[8] ). The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators conducted a study in which patients with history of transient ischemic attack or thrombotic stroke were allocated into two groups, one treated with statin and the other group with placebo, after conducting this study
According to a new study found that people with abnormal heart rhythm called atrial fibrillation that commonly used painkillers can increase the risk of bleeding and blood clots.This risk is even higher among those who are taking blood thinners with pain medications, such as anti-inflammatory drugs, which is not Dr. Nath Islamic Guinea (Gunnar Gislason) said that if you add NSAIDs on blood thinners, you have double the risk of bleeding.He noted that people with atrial fibrillation taking blood thinners to reduce the risk of ischemic stroke. Atrial fibrillation causes the upper recording rapid heart contractions and irregular. Twisted contract will form a blood clot, which can lead to ischemic stroke if it's from the heart and go to the brain.Dr.
NSAIDs can lead to an increased risk of adverse cardiovascular thrombotic events, including MI and stroke. Platelet adhesion and aggregation may be decreased with Naproxen, prolonging bleeding time. Hematologic side effects induced by Naproxen include platelet dysfunction resulting in increased bleeding times, decreased hematocrit, eosinophilia, granulocytopenia, neutropenia, leukopenia, thrombocytopenia, and agranulocytosis. Due to hematologic side effects, a complete blood count and coagulants must be monitored closely (Lexi-Comp,